13F Pro

SEC Form 4 reporting owner

Link William J PHD

Link William J PHD has filed 20 Form 4 transactions reported between December 15, 2025 and September 15, 2026, as Director of Tarsus Pharmaceuticals, Inc., a reporting owner of RxSight, Inc. and a reporting owner of LENSAR, Inc..

Name as filed: LINK WILLIAM J PHD

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$4.5M
13 lines
Companies
3
with Form 4 filings
Latest transaction
Sep 15, 2026
transaction date

Roles and reported holdings

  • TARSTarsus Pharmaceuticals, Inc.
    Dec 15, 2025 – Sep 15, 2026

    Director

    Held directly94,487 sh as of Sep 15, 2026 · Form 4
    Held indirectly (latest line)0 sh as of Dec 15, 2025 · Form 4

    24 months: $4.5M sold

  • RXSTRxSight, Inc.
    Jun 17, 2026

    Reporting owner

    No common-stock holding reported on a purchase, sale, gift or withholding line.

  • LNSRLENSAR, Inc.
    Jun 3, 2026

    Reporting owner

    No common-stock holding reported on a purchase, sale, gift or withholding line.

Transaction history

All 20 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 15, 2026TARSDirectorOpen-market saleCode S · direct66$5K@ $80.01Form 4
Sep 15, 2026TARSDirectorOpen-market saleCode S · direct759$60K@ $79.00Form 4
Sep 15, 2026TARSDirectorOpen-market saleCode S · direct11,675$915K@ $78.33Form 4
Sep 15, 2026TARSDirectorOption exerciseCode M · direct201—Form 4
Jun 25, 2026TARSDirectorGrant or awardCode A · direct806—Form 4
Jun 25, 2026TARSDirectorGrant or awardCode A · direct2,417—Form 4
Jun 25, 2026TARSDirectorGrant or awardCode A · direct3,837—Form 4
Jun 17, 2026RXSTGrant or awardCode A · direct37,037—Form 4
Jun 15, 2026TARSDirectorOpen-market saleCode S · direct1,928$121K@ $62.94Form 4
Jun 15, 2026TARSDirectorOpen-market saleCode S · direct10,572$655K@ $61.97Form 4
Jun 12, 2026TARSDirectorOption exerciseCode M · direct2,954—Form 4
Jun 3, 2026LNSRGrant or awardCode A · direct17,421—Form 4
Mar 16, 2026TARSDirectorOpen-market saleCode S · direct493$34K@ $69.75Form 4
Mar 16, 2026TARSDirectorOpen-market saleCode S · direct8,378$578K@ $69.03Form 4
Mar 16, 2026TARSDirectorOpen-market saleCode S · direct3,629$247K@ $68.09Form 4
Dec 15, 2025TARSDirectorOpen-market saleCode S · indirect4,766$388K@ $81.50Form 4
Dec 15, 2025TARSDirectorOpen-market saleCode S · indirect5,680$458K@ $80.71Form 4
Dec 15, 2025TARSDirectorOpen-market saleCode S · direct1,148$95K@ $82.39Form 4
Dec 15, 2025TARSDirectorOpen-market saleCode S · direct6,306$516K@ $81.75Form 4
Dec 15, 2025TARSDirectorOpen-market saleCode S · direct5,046$408K@ $80.80Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.